Lianne Simone (Wener) Gensler MD
Spondyloarthropathy
Professor of Medicine
Join to View Full Profile
University of California San Francisco533 Parnassus Avenue U384San Francisco, CA 94143
Phone+1 415-353-2497
Dr. Gensler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lianne Gensler is a rheumatologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Medical Center and Zuckerberg San Francisco General Hospital and Trauma Center. She received her medical degree from University of California Irvine School of Medicine and has been in practice 16 years. She specializes in spondyloarthropathy.
Education & Training
University of California (San Francisco)Fellowship, Rheumatology, 2005 - 2008- University of California (San Francisco)Residency, Internal Medicine, 2001 - 2005
University of California, Irvine, School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2003 - 2026
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow American College of Rheumatology
Clinical Trials
- Novel Quantitative MRI for Axial Spondyloarthritis Start of enrollment: 2020 Jan 15
Publications & Presentations
PubMed
- Long-term safety of bimekizumab in adult patients with axial spondyloarthritis or psoriatic arthritis: pooled results from integrated phase IIb/III clinical studies.Philip J Mease, Lianne S Gensler, Ana-Maria Orbai, Richard B Warren, Rajan Bajracharya
RMD Open. 2025-04-06 - 2 citationsThe Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondy...Denis Poddubnyy, Victoria Navarro-Compán, Murat Torgutalp, Suzanne Arends, Sibel Zehra Aydin
Annals of the Rheumatic Diseases. 2025-04-01 - A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment.Atul Deodhar, Alan J Kivitz, Marina Magrey, Jessica A Walsh, Philip J Mease
Rheumatology. 2025-04-01
Press Mentions
An Approach to Physical Activity & Exercise in Axial SpondyloarthritisDecember 9th, 2024- ACR Honors Distinguished Fellows: Class of 2024November 18th, 2024
- When Three Shots Are Not EnoughJanuary 3rd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
